View Future GrowthYongyue Science&TechnologyLtd 과거 순이익 실적과거 기준 점검 0/6Yongyue Science&TechnologyLtd 의 수입은 연평균 -49.2%의 비율로 감소해 온 반면, Chemicals 산업은 연평균 5.6%의 비율로 감소했습니다. 매출은 연평균 4.1%의 비율로 감소해 왔습니다.핵심 정보-49.24%순이익 성장률-49.06%주당순이익(EPS) 성장률Chemicals 산업 성장률12.10%매출 성장률-4.14%자기자본이익률-23.12%순이익률-15.93%최근 순이익 업데이트31 Mar 2026최근 과거 실적 업데이트Reported Earnings • Apr 21Full year 2025 earnings released: CN¥0.15 loss per share (vs CN¥0.46 loss in FY 2024)Full year 2025 results: CN¥0.15 loss per share (improved from CN¥0.46 loss in FY 2024). Revenue: CN¥329.7m (down 11% from FY 2024). Net loss: CN¥53.1m (loss narrowed 68% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.공시 • Mar 30Yongyue Science&Technology Co.,Ltd to Report Q1, 2026 Results on Apr 30, 2026Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2026 results on Apr 30, 2026공시 • Dec 26Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2025 Results on Apr 21, 2026Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2025 results on Apr 21, 2026공시 • Sep 30Yongyue Science&Technology Co.,Ltd to Report Q3, 2025 Results on Oct 31, 2025Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2025 results on Oct 31, 2025공시 • Jun 30Yongyue Science&Technology Co.,Ltd to Report First Half, 2025 Results on Aug 30, 2025Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2025 results on Aug 30, 2025Reported Earnings • Apr 03Full year 2024 earnings released: CN¥0.46 loss per share (vs CN¥0.19 loss in FY 2023)Full year 2024 results: CN¥0.46 loss per share (further deteriorated from CN¥0.19 loss in FY 2023). Revenue: CN¥370.4m (up 9.7% from FY 2023). Net loss: CN¥165.5m (loss widened 136% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.모든 업데이트 보기Recent updatesNew Risk • Apr 21New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CN¥31m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥31m free cash flow). Earnings have declined by 57% per year over the past 5 years.Reported Earnings • Apr 21Full year 2025 earnings released: CN¥0.15 loss per share (vs CN¥0.46 loss in FY 2024)Full year 2025 results: CN¥0.15 loss per share (improved from CN¥0.46 loss in FY 2024). Revenue: CN¥329.7m (down 11% from FY 2024). Net loss: CN¥53.1m (loss narrowed 68% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.공시 • Apr 21Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 15, 2026Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 15, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Quanzhou, Fujian China공시 • Mar 30Yongyue Science&Technology Co.,Ltd to Report Q1, 2026 Results on Apr 30, 2026Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2026 results on Apr 30, 2026공시 • Dec 26Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2025 Results on Apr 21, 2026Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2025 results on Apr 21, 2026New Risk • Dec 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.5% average weekly change).Board Change • Oct 29Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Shuzhi Xie was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Sep 30Yongyue Science&Technology Co.,Ltd to Report Q3, 2025 Results on Oct 31, 2025Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2025 results on Oct 31, 2025New Risk • Jul 08New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 9.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥38m free cash flow). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Earnings have declined by 72% per year over the past 5 years.공시 • Jun 30Yongyue Science&Technology Co.,Ltd to Report First Half, 2025 Results on Aug 30, 2025Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2025 results on Aug 30, 2025New Risk • Jun 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥38m free cash flow). Earnings have declined by 72% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change).New Risk • May 08New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CN¥38m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥38m free cash flow). Earnings have declined by 72% per year over the past 5 years.Reported Earnings • Apr 03Full year 2024 earnings released: CN¥0.46 loss per share (vs CN¥0.19 loss in FY 2023)Full year 2024 results: CN¥0.46 loss per share (further deteriorated from CN¥0.19 loss in FY 2023). Revenue: CN¥370.4m (up 9.7% from FY 2023). Net loss: CN¥165.5m (loss widened 136% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.공시 • Apr 03Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 09, 2025Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 09, 2025, at 14:00 China Standard Time. Location: Office Building 5, College Student Entrepreneurship Park, East of Yongsheng Road and South of Ruifeng Road, Dazhong Subdistrict, Dafeng District, Yancheng, Jiangsu China공시 • Mar 28Yongyue Science&Technology Co.,Ltd to Report Q1, 2025 Results on Apr 30, 2025Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2025 results on Apr 30, 2025공시 • Dec 27Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2024 Results on Mar 31, 2025Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2024 results on Mar 31, 2025분석 기사 • Nov 29Optimistic Investors Push Yongyue Science&Technology Co.,Ltd (SHSE:603879) Shares Up 32% But Growth Is LackingYongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shares have continued their recent momentum with a 32% gain in the...Reported Earnings • Nov 02Third quarter 2024 earnings released: CN¥0.025 loss per share (vs CN¥0.037 loss in 3Q 2023)Third quarter 2024 results: CN¥0.025 loss per share (improved from CN¥0.037 loss in 3Q 2023). Revenue: CN¥103.9m (up 16% from 3Q 2023). Net loss: CN¥8.91m (loss narrowed 32% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.공시 • Sep 30Yongyue Science&Technology Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024Reported Earnings • Aug 29Second quarter 2024 earnings released: CN¥0.036 loss per share (vs CN¥0.032 loss in 2Q 2023)Second quarter 2024 results: CN¥0.036 loss per share (further deteriorated from CN¥0.032 loss in 2Q 2023). Revenue: CN¥94.0m (up 7.4% from 2Q 2023). Net loss: CN¥12.8m (loss widened 11% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance.분석 기사 • Jul 25Yongyue Science&Technology Co.,Ltd (SHSE:603879) Stock Rockets 29% As Investors Are Less Pessimistic Than ExpectedYongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shareholders are no doubt pleased to see that the share price has...공시 • Jun 28Yongyue Science&Technology Co.,Ltd to Report First Half, 2024 Results on Aug 29, 2024Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2024 results on Aug 29, 2024New Risk • Jun 25New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: CN¥707.0m (US$97.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 77% per year over the past 5 years. Minor Risk Market cap is less than US$100m (CN¥707.0m market cap, or US$97.3m).분석 기사 • Jun 05Risks Still Elevated At These Prices As Yongyue Science&Technology Co.,Ltd (SHSE:603879) Shares Dive 52%Yongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shareholders that were waiting for something to happen have been...New Risk • Jun 05New major risk - Revenue and earnings growthEarnings have declined by 77% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 77% per year over the past 5 years.New Risk • May 14New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 74% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).공시 • May 01Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 30, 2024Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 30, 2024, at 14:00 China Standard Time. Location: 7F, No. 16, Hongwu North Road, Xuanwu District, Nanjing, Jiangsu China분석 기사 • Apr 15Yongyue Science&Technology Co.,Ltd (SHSE:603879) May Have Run Too Fast Too Soon With Recent 29% Price PlummetYongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shares have had a horrible month, losing 29% after a relatively good...공시 • Mar 29Yongyue Science&Technology Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2024 results on Apr 30, 2024New Risk • Feb 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 74% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).공시 • Feb 27Yongyue Science&Technology Co.,Ltd (SHSE:603879) announces an Equity Buyback for CNY 30 million worth of its shares.Yongyue Science&Technology Co.,Ltd (SHSE:603879) announces a share repurchase program. Under the program, the company will repurchase up to CNY 30 million worth of its shares. The shares will be repurchased at a price not more than CNY 6 per share. The repurchased shares will be used to safeguard the company's value and shareholders' rights. The program will be valid for a period of 3 months.분석 기사 • Feb 26Yongyue Science&Technology Co.,Ltd's (SHSE:603879) Popularity With Investors Under Threat As Stock Sinks 26%To the annoyance of some shareholders, Yongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shares are down a...공시 • Dec 29Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2023 Results on Apr 30, 2024Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2023 results on Apr 30, 2024Reported Earnings • Aug 30Second quarter 2023 earnings released: CN¥0.032 loss per share (vs CN¥0.008 loss in 2Q 2022)Second quarter 2023 results: CN¥0.032 loss per share (further deteriorated from CN¥0.008 loss in 2Q 2022). Revenue: CN¥87.5m (up 10% from 2Q 2022). Net loss: CN¥11.5m (loss widened 291% from 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 136 percentage points per year, which is a significant difference in performance.New Risk • Jul 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.7% average weekly change).공시 • Jun 28Yongyue Science&Technology Co.,Ltd to Report First Half, 2023 Results on Aug 30, 2023Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2023 results on Aug 30, 2023Reported Earnings • Apr 29First quarter 2023 earnings released: CN¥0.017 loss per share (vs CN¥0.006 loss in 1Q 2022)First quarter 2023 results: CN¥0.017 loss per share (further deteriorated from CN¥0.006 loss in 1Q 2022). Revenue: CN¥60.0m (up 13% from 1Q 2022). Net loss: CN¥6.00m (loss widened 185% from 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance.Board Change • Nov 16Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. 2 independent directors (4 non-independent directors). GM & Vice Chairman Weida Xu is the most experienced director on the board, commencing their role in 2017. Independent Director Yu Wu was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Reported Earnings • Oct 28Third quarter 2022 earnings released: CN¥0.032 loss per share (vs CN¥0.003 profit in 3Q 2021)Third quarter 2022 results: CN¥0.032 loss per share (down from CN¥0.003 profit in 3Q 2021). Revenue: CN¥84.5m (down 18% from 3Q 2021). Net loss: CN¥11.5m (down CN¥12.6m from profit in 3Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 31Second quarter 2022 earnings released: CN¥0.008 loss per share (vs CN¥0.012 profit in 2Q 2021)Second quarter 2022 results: CN¥0.008 loss per share (down from CN¥0.012 profit in 2Q 2021). Revenue: CN¥79.4m (down 32% from 2Q 2021). Net loss: CN¥2.95m (down 181% from profit in 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.Board Change • Aug 25Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. 2 independent directors (4 non-independent directors). GM & Vice Chairman Weida Xu is the most experienced director on the board, commencing their role in 2017. Independent Director Yu Wu was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Reported Earnings • May 02First quarter 2022 earnings released: CN¥0.006 loss per share (vs CN¥0.008 profit in 1Q 2021)First quarter 2022 results: CN¥0.006 loss per share (down from CN¥0.008 profit in 1Q 2021). Revenue: CN¥53.2m (down 43% from 1Q 2021). Net loss: CN¥2.11m (down 166% from profit in 1Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Apr 21Full year 2021 earnings released: EPS: CN¥0.018 (vs CN¥0.015 in FY 2020)Full year 2021 results: EPS: CN¥0.018 (up from CN¥0.015 in FY 2020). Revenue: CN¥396.2m (down 2.5% from FY 2020). Net income: CN¥6.43m (up 2.8% from FY 2020). Profit margin: 1.6% (up from 1.5% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.003 (vs CN¥0.008 loss in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: CN¥103.4m (down 10.0% from 3Q 2020). Net income: CN¥1.13m (up CN¥3.91m from 3Q 2020). Profit margin: 1.1% (up from net loss in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.Reported Earnings • Aug 20Second quarter 2021 earnings released: EPS CN¥0.012 (vs CN¥0.014 in 2Q 2020)The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥116.1m (up 33% from 2Q 2020). Net income: CN¥3.64m (down 27% from 2Q 2020). Profit margin: 3.1% (down from 5.7% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.Reported Earnings • Apr 20Full year 2020 earnings released: EPS CN¥0.02 (vs CN¥0.086 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥406.4m (down 5.2% from FY 2019). Net income: CN¥6.25m (down 74% from FY 2019). Profit margin: 1.5% (down from 5.7% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Feb 08New 90-day low: CN¥6.36The company is down 25% from its price of CN¥8.49 on 10 November 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.공시 • Jan 22Jiangsu Huaying Enterprise Management Co., Ltd. completed the acquisition of 17.1% stake in Yongyue Science&Technology Co.,Ltd (SHSE:603879) from Fu Wenchang, Fu Shuifa, Fu Wenying and Chen Zhishan.Jiangsu Huaying Enterprise Management Co., Ltd. signed a share transfer intention agreement to acquire 17.1% stake in Yongyue Science&Technology Co.,Ltd (SHSE:603879) from Fu Wenchang, Fu Shuifa, Fu Wenying and Chen Zhishan for approximately CNY 620 million on November 11, 2020. Under the terms of the transaction, Jiangsu Huaying will acquire 47.8 million shares of Yongyue Science&Technology for CNY 12.8 per share. Within 3 working days from the date of signing the agreement, a deposit of CNY 100 million shall be paid. Before the transaction, Fu Wenchang, Fu Shuifa, Fu Xiuzhen and Fu Wenying held 102.9 million shares or 36.83% stake while Chen Zhishan held 37.6 million shares or 13.46% stake in in Yongyue Science&Technology. Upon completion of the transaction, Fu Wenchang, Fu Shuifa, Fu Xiuzhen and Fu Wenying will hold 64.5 million shares or 23.08% stake while Chen Zhishan will hold 28.2 million shares or 10.1% stake. Jiangsu Huaying Enterprise Management Co., Ltd. completed the acquisition of 17.1% stake in Yongyue Science&Technology Co.,Ltd (SHSE:603879) from Fu Wenchang, Fu Shuifa, Fu Wenying and Chen Zhishan on January 20, 2021.Is New 90 Day High Low • Jan 06New 90-day low: CN¥7.18The company is down 2.0% from its price of CN¥7.36 on 30 September 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period.Is New 90 Day High Low • Dec 01New 90-day high: CN¥8.51The company is up 3.0% from its price of CN¥8.30 on 02 September 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 3.0% over the same period.Reported Earnings • Oct 25Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥2.82m, down 88% from the prior year. Total revenue was CN¥370.5m over the last 12 months, down 22% from the prior year.공시 • Oct 20Yongyue Science&Technology Co.,Ltd to Report Q3, 2020 Results on Oct 24, 2020Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2020 results on Oct 24, 2020공시 • Jul 09Yongyue Science&Technology Co.,Ltd to Report First Half, 2020 Results on Aug 21, 2020Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2020 results on Aug 21, 2020매출 및 비용 세부 내역Yongyue Science&TechnologyLtd가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이SHSE:603879 매출, 비용 및 순이익 (CNY Millions)날짜매출순이익일반관리비연구개발비31 Mar 26336-5441931 Dec 25330-5341930 Sep 25338-141341230 Jun 25361-147421331 Mar 25366-159511231 Dec 24370-161611330 Sep 24363-73851130 Jun 24349-77871431 Mar 24342-76831631 Dec 23338-70771730 Sep 23316-53771530 Jun 23311-52761231 Mar 23303-43711131 Dec 22296-3968930 Sep 22301-18451030 Jun 22320-5371031 Mar 223571331131 Dec 213966321430 Sep 2146416381530 Jun 2147512351631 Mar 2144713381631 Dec 204066401430 Sep 203703381330 Jun 2036013421231 Mar 2038515411331 Dec 1942924401330 Sep 1947524411630 Jun 1955429401931 Mar 1960234402131 Dec 1860837382230 Sep 1859742381930 Jun 1855843262931 Mar 1855245302431 Dec 1755944342030 Sep 1756551341630 Jun 175754949031 Mar 175664847031 Dec 165364746031 Dec 1554942450양질의 수익: 603879 은(는) 현재 수익성이 없습니다.이익 마진 증가: 603879는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 603879은 수익성이 없으며 지난 5년 동안 손실이 연평균 49.2% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 603879의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: 603879은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(3.7%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: 603879는 현재 수익성이 없으므로 자본 수익률이 음수(-23.12%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/12 10:10종가2026/06/12 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Yongyue Science&Technology Co.,Ltd는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Apr 21Full year 2025 earnings released: CN¥0.15 loss per share (vs CN¥0.46 loss in FY 2024)Full year 2025 results: CN¥0.15 loss per share (improved from CN¥0.46 loss in FY 2024). Revenue: CN¥329.7m (down 11% from FY 2024). Net loss: CN¥53.1m (loss narrowed 68% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
공시 • Mar 30Yongyue Science&Technology Co.,Ltd to Report Q1, 2026 Results on Apr 30, 2026Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2026 results on Apr 30, 2026
공시 • Dec 26Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2025 Results on Apr 21, 2026Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2025 results on Apr 21, 2026
공시 • Sep 30Yongyue Science&Technology Co.,Ltd to Report Q3, 2025 Results on Oct 31, 2025Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2025 results on Oct 31, 2025
공시 • Jun 30Yongyue Science&Technology Co.,Ltd to Report First Half, 2025 Results on Aug 30, 2025Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2025 results on Aug 30, 2025
Reported Earnings • Apr 03Full year 2024 earnings released: CN¥0.46 loss per share (vs CN¥0.19 loss in FY 2023)Full year 2024 results: CN¥0.46 loss per share (further deteriorated from CN¥0.19 loss in FY 2023). Revenue: CN¥370.4m (up 9.7% from FY 2023). Net loss: CN¥165.5m (loss widened 136% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
New Risk • Apr 21New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CN¥31m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥31m free cash flow). Earnings have declined by 57% per year over the past 5 years.
Reported Earnings • Apr 21Full year 2025 earnings released: CN¥0.15 loss per share (vs CN¥0.46 loss in FY 2024)Full year 2025 results: CN¥0.15 loss per share (improved from CN¥0.46 loss in FY 2024). Revenue: CN¥329.7m (down 11% from FY 2024). Net loss: CN¥53.1m (loss narrowed 68% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
공시 • Apr 21Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 15, 2026Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 15, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Quanzhou, Fujian China
공시 • Mar 30Yongyue Science&Technology Co.,Ltd to Report Q1, 2026 Results on Apr 30, 2026Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2026 results on Apr 30, 2026
공시 • Dec 26Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2025 Results on Apr 21, 2026Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2025 results on Apr 21, 2026
New Risk • Dec 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.5% average weekly change).
Board Change • Oct 29Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Shuzhi Xie was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Sep 30Yongyue Science&Technology Co.,Ltd to Report Q3, 2025 Results on Oct 31, 2025Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2025 results on Oct 31, 2025
New Risk • Jul 08New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 9.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥38m free cash flow). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Earnings have declined by 72% per year over the past 5 years.
공시 • Jun 30Yongyue Science&Technology Co.,Ltd to Report First Half, 2025 Results on Aug 30, 2025Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2025 results on Aug 30, 2025
New Risk • Jun 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥38m free cash flow). Earnings have declined by 72% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change).
New Risk • May 08New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CN¥38m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥38m free cash flow). Earnings have declined by 72% per year over the past 5 years.
Reported Earnings • Apr 03Full year 2024 earnings released: CN¥0.46 loss per share (vs CN¥0.19 loss in FY 2023)Full year 2024 results: CN¥0.46 loss per share (further deteriorated from CN¥0.19 loss in FY 2023). Revenue: CN¥370.4m (up 9.7% from FY 2023). Net loss: CN¥165.5m (loss widened 136% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
공시 • Apr 03Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 09, 2025Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 09, 2025, at 14:00 China Standard Time. Location: Office Building 5, College Student Entrepreneurship Park, East of Yongsheng Road and South of Ruifeng Road, Dazhong Subdistrict, Dafeng District, Yancheng, Jiangsu China
공시 • Mar 28Yongyue Science&Technology Co.,Ltd to Report Q1, 2025 Results on Apr 30, 2025Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2025 results on Apr 30, 2025
공시 • Dec 27Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2024 Results on Mar 31, 2025Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2024 results on Mar 31, 2025
분석 기사 • Nov 29Optimistic Investors Push Yongyue Science&Technology Co.,Ltd (SHSE:603879) Shares Up 32% But Growth Is LackingYongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shares have continued their recent momentum with a 32% gain in the...
Reported Earnings • Nov 02Third quarter 2024 earnings released: CN¥0.025 loss per share (vs CN¥0.037 loss in 3Q 2023)Third quarter 2024 results: CN¥0.025 loss per share (improved from CN¥0.037 loss in 3Q 2023). Revenue: CN¥103.9m (up 16% from 3Q 2023). Net loss: CN¥8.91m (loss narrowed 32% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.
공시 • Sep 30Yongyue Science&Technology Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024
Reported Earnings • Aug 29Second quarter 2024 earnings released: CN¥0.036 loss per share (vs CN¥0.032 loss in 2Q 2023)Second quarter 2024 results: CN¥0.036 loss per share (further deteriorated from CN¥0.032 loss in 2Q 2023). Revenue: CN¥94.0m (up 7.4% from 2Q 2023). Net loss: CN¥12.8m (loss widened 11% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance.
분석 기사 • Jul 25Yongyue Science&Technology Co.,Ltd (SHSE:603879) Stock Rockets 29% As Investors Are Less Pessimistic Than ExpectedYongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shareholders are no doubt pleased to see that the share price has...
공시 • Jun 28Yongyue Science&Technology Co.,Ltd to Report First Half, 2024 Results on Aug 29, 2024Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2024 results on Aug 29, 2024
New Risk • Jun 25New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: CN¥707.0m (US$97.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 77% per year over the past 5 years. Minor Risk Market cap is less than US$100m (CN¥707.0m market cap, or US$97.3m).
분석 기사 • Jun 05Risks Still Elevated At These Prices As Yongyue Science&Technology Co.,Ltd (SHSE:603879) Shares Dive 52%Yongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shareholders that were waiting for something to happen have been...
New Risk • Jun 05New major risk - Revenue and earnings growthEarnings have declined by 77% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 77% per year over the past 5 years.
New Risk • May 14New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 74% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).
공시 • May 01Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 30, 2024Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 30, 2024, at 14:00 China Standard Time. Location: 7F, No. 16, Hongwu North Road, Xuanwu District, Nanjing, Jiangsu China
분석 기사 • Apr 15Yongyue Science&Technology Co.,Ltd (SHSE:603879) May Have Run Too Fast Too Soon With Recent 29% Price PlummetYongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shares have had a horrible month, losing 29% after a relatively good...
공시 • Mar 29Yongyue Science&Technology Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2024 results on Apr 30, 2024
New Risk • Feb 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 74% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).
공시 • Feb 27Yongyue Science&Technology Co.,Ltd (SHSE:603879) announces an Equity Buyback for CNY 30 million worth of its shares.Yongyue Science&Technology Co.,Ltd (SHSE:603879) announces a share repurchase program. Under the program, the company will repurchase up to CNY 30 million worth of its shares. The shares will be repurchased at a price not more than CNY 6 per share. The repurchased shares will be used to safeguard the company's value and shareholders' rights. The program will be valid for a period of 3 months.
분석 기사 • Feb 26Yongyue Science&Technology Co.,Ltd's (SHSE:603879) Popularity With Investors Under Threat As Stock Sinks 26%To the annoyance of some shareholders, Yongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shares are down a...
공시 • Dec 29Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2023 Results on Apr 30, 2024Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2023 results on Apr 30, 2024
Reported Earnings • Aug 30Second quarter 2023 earnings released: CN¥0.032 loss per share (vs CN¥0.008 loss in 2Q 2022)Second quarter 2023 results: CN¥0.032 loss per share (further deteriorated from CN¥0.008 loss in 2Q 2022). Revenue: CN¥87.5m (up 10% from 2Q 2022). Net loss: CN¥11.5m (loss widened 291% from 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 136 percentage points per year, which is a significant difference in performance.
New Risk • Jul 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.7% average weekly change).
공시 • Jun 28Yongyue Science&Technology Co.,Ltd to Report First Half, 2023 Results on Aug 30, 2023Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2023 results on Aug 30, 2023
Reported Earnings • Apr 29First quarter 2023 earnings released: CN¥0.017 loss per share (vs CN¥0.006 loss in 1Q 2022)First quarter 2023 results: CN¥0.017 loss per share (further deteriorated from CN¥0.006 loss in 1Q 2022). Revenue: CN¥60.0m (up 13% from 1Q 2022). Net loss: CN¥6.00m (loss widened 185% from 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance.
Board Change • Nov 16Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. 2 independent directors (4 non-independent directors). GM & Vice Chairman Weida Xu is the most experienced director on the board, commencing their role in 2017. Independent Director Yu Wu was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Reported Earnings • Oct 28Third quarter 2022 earnings released: CN¥0.032 loss per share (vs CN¥0.003 profit in 3Q 2021)Third quarter 2022 results: CN¥0.032 loss per share (down from CN¥0.003 profit in 3Q 2021). Revenue: CN¥84.5m (down 18% from 3Q 2021). Net loss: CN¥11.5m (down CN¥12.6m from profit in 3Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 31Second quarter 2022 earnings released: CN¥0.008 loss per share (vs CN¥0.012 profit in 2Q 2021)Second quarter 2022 results: CN¥0.008 loss per share (down from CN¥0.012 profit in 2Q 2021). Revenue: CN¥79.4m (down 32% from 2Q 2021). Net loss: CN¥2.95m (down 181% from profit in 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.
Board Change • Aug 25Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. 2 independent directors (4 non-independent directors). GM & Vice Chairman Weida Xu is the most experienced director on the board, commencing their role in 2017. Independent Director Yu Wu was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Reported Earnings • May 02First quarter 2022 earnings released: CN¥0.006 loss per share (vs CN¥0.008 profit in 1Q 2021)First quarter 2022 results: CN¥0.006 loss per share (down from CN¥0.008 profit in 1Q 2021). Revenue: CN¥53.2m (down 43% from 1Q 2021). Net loss: CN¥2.11m (down 166% from profit in 1Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Apr 21Full year 2021 earnings released: EPS: CN¥0.018 (vs CN¥0.015 in FY 2020)Full year 2021 results: EPS: CN¥0.018 (up from CN¥0.015 in FY 2020). Revenue: CN¥396.2m (down 2.5% from FY 2020). Net income: CN¥6.43m (up 2.8% from FY 2020). Profit margin: 1.6% (up from 1.5% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.003 (vs CN¥0.008 loss in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: CN¥103.4m (down 10.0% from 3Q 2020). Net income: CN¥1.13m (up CN¥3.91m from 3Q 2020). Profit margin: 1.1% (up from net loss in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 20Second quarter 2021 earnings released: EPS CN¥0.012 (vs CN¥0.014 in 2Q 2020)The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥116.1m (up 33% from 2Q 2020). Net income: CN¥3.64m (down 27% from 2Q 2020). Profit margin: 3.1% (down from 5.7% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
Reported Earnings • Apr 20Full year 2020 earnings released: EPS CN¥0.02 (vs CN¥0.086 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥406.4m (down 5.2% from FY 2019). Net income: CN¥6.25m (down 74% from FY 2019). Profit margin: 1.5% (down from 5.7% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Feb 08New 90-day low: CN¥6.36The company is down 25% from its price of CN¥8.49 on 10 November 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.
공시 • Jan 22Jiangsu Huaying Enterprise Management Co., Ltd. completed the acquisition of 17.1% stake in Yongyue Science&Technology Co.,Ltd (SHSE:603879) from Fu Wenchang, Fu Shuifa, Fu Wenying and Chen Zhishan.Jiangsu Huaying Enterprise Management Co., Ltd. signed a share transfer intention agreement to acquire 17.1% stake in Yongyue Science&Technology Co.,Ltd (SHSE:603879) from Fu Wenchang, Fu Shuifa, Fu Wenying and Chen Zhishan for approximately CNY 620 million on November 11, 2020. Under the terms of the transaction, Jiangsu Huaying will acquire 47.8 million shares of Yongyue Science&Technology for CNY 12.8 per share. Within 3 working days from the date of signing the agreement, a deposit of CNY 100 million shall be paid. Before the transaction, Fu Wenchang, Fu Shuifa, Fu Xiuzhen and Fu Wenying held 102.9 million shares or 36.83% stake while Chen Zhishan held 37.6 million shares or 13.46% stake in in Yongyue Science&Technology. Upon completion of the transaction, Fu Wenchang, Fu Shuifa, Fu Xiuzhen and Fu Wenying will hold 64.5 million shares or 23.08% stake while Chen Zhishan will hold 28.2 million shares or 10.1% stake. Jiangsu Huaying Enterprise Management Co., Ltd. completed the acquisition of 17.1% stake in Yongyue Science&Technology Co.,Ltd (SHSE:603879) from Fu Wenchang, Fu Shuifa, Fu Wenying and Chen Zhishan on January 20, 2021.
Is New 90 Day High Low • Jan 06New 90-day low: CN¥7.18The company is down 2.0% from its price of CN¥7.36 on 30 September 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period.
Is New 90 Day High Low • Dec 01New 90-day high: CN¥8.51The company is up 3.0% from its price of CN¥8.30 on 02 September 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 3.0% over the same period.
Reported Earnings • Oct 25Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥2.82m, down 88% from the prior year. Total revenue was CN¥370.5m over the last 12 months, down 22% from the prior year.
공시 • Oct 20Yongyue Science&Technology Co.,Ltd to Report Q3, 2020 Results on Oct 24, 2020Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2020 results on Oct 24, 2020
공시 • Jul 09Yongyue Science&Technology Co.,Ltd to Report First Half, 2020 Results on Aug 21, 2020Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2020 results on Aug 21, 2020